Correction: Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease (Genome Medicine, (2022), 14, 1, (67), 10.1186/s13073-022-01071-5)

Gabriella Assante, Sriram Chandrasekaran, Stanley Ng, Aikaterini Tourna, Carolina H. Chung, Kowsar A. Isse, Jasmine L. Banks, Ugo Soffientini, Celine Filippi, Anil Dhawan, Mo Liu, Steven G. Rozen, Matthew Hoare, Peter Campbell, J. William O. Ballard, Nigel Turner, Margaret J. Morris, Shilpa Chokshi, Neil A. Youngson*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The original publication of this article [1] contained an incorrect funding acknowledgement. The incorrect and correct information is listed in this correction article. The original article has been updated. Camille and Henry Dreyfus Foundation and R35 GM13779501 from the National Institutes of Health (NIH) USA to S. Chandrasekaran Camille and Henry Dreyfus Foundation and startup funds from the University of Michigan to S. Chandrasekaran.

Original languageEnglish
Article number38
JournalGenome Medicine
Volume15
Issue number1
DOIs
Publication statusPublished - Dec 2023
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Genetics (clinical)

Fingerprint

Dive into the research topics of 'Correction: Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease (Genome Medicine, (2022), 14, 1, (67), 10.1186/s13073-022-01071-5)'. Together they form a unique fingerprint.

Cite this